• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳突腔生物活性玻璃填塞:一项初步研究。

Mastoidectomy cavity obliteration with bioactive glass: a pilot study.

机构信息

ENT Department, Päijät-Häme Central Hospital, Lahti, Finland.

出版信息

Otolaryngol Head Neck Surg. 2012 Jul;147(1):119-26. doi: 10.1177/0194599812438168. Epub 2012 Feb 27.

DOI:10.1177/0194599812438168
PMID:22371341
Abstract

OBJECTIVE

To show that mastoid cavities with continuous infections and cleaning problems can be obliterated with bioactive glass (BG) and to present results of a pilot study for 16 operations on adults.

STUDY DESIGN

Case series with planned data collection.

SETTING

Päijät-Häme Central Hospital, Finland-a single ear, nose, and throat (ENT) hospital department serving a population of 216,000.

SUBJECTS AND METHODS

Fourteen patients had a large open radical cavity with recurrent infections. Two ears had discharge and pain after simple mastoidectomy. A re-mastoidectomy included support of the cavity skin and obliteration with BG. The mean follow-up time was 2.2 years.

RESULTS

All ears became dry. One reoperation was needed as the fascia support to the ear canal (EC) skin was too weak, and part of the BG leaked into the EC. The ear stayed dry, and the missing BG was replaced in a reoperation. A slightly short musculoperiosteal flap supported the EC skin in 1 ear. A minor amount of BG leaked into the EC. The ear stayed dry. The aim was an ample ear canal. One ear was overfilled and required meatoplasty. Simple mastoid cavities were isolated from the middle ear and become asymptomatic.

CONCLUSIONS

In this pilot study, BG works safely and with success as an obliteration material in problematic open radical cavities. Bioactive glass seems to tolerate chronic infection in the mastoid and prevent postoperative infections.

摘要

目的

展示生物活性玻璃(BG)可用于封闭持续感染和清洁问题严重的乳突腔,并介绍针对 16 例成人手术的初步研究结果。

研究设计

有计划数据收集的病例系列。

设置

芬兰派亚特-哈梅中央医院,这是一家专门从事耳鼻喉科(ENT)的医院,服务于 21.6 万人口。

受试者和方法

14 例患者存在大的开放式根治性乳突腔,伴有反复感染。2 例患者在单纯乳突切除术后出现溢液和疼痛。再行乳突切除术,包括耳腔皮肤的支撑和 BG 封闭。平均随访时间为 2.2 年。

结果

所有耳朵均干燥。1 例因耳腔皮肤筋膜支撑力不足,部分 BG 漏入耳腔,需再次手术。耳朵保持干燥,且在再次手术中更换了缺失的 BG。1 例因肌骨膜瓣略短,支撑耳腔皮肤,少量 BG 漏入耳腔,耳朵保持干燥。手术目的是形成宽敞的耳道。1 例耳朵填充过度,需行耳成形术。单纯乳突腔与中耳隔离,无症状。

结论

在这项初步研究中,BG 作为一种封闭材料,在有问题的开放式根治性乳突腔中安全有效。生物活性玻璃似乎能耐受乳突内的慢性感染,并预防术后感染。

相似文献

1
Mastoidectomy cavity obliteration with bioactive glass: a pilot study.乳突腔生物活性玻璃填塞:一项初步研究。
Otolaryngol Head Neck Surg. 2012 Jul;147(1):119-26. doi: 10.1177/0194599812438168. Epub 2012 Feb 27.
2
A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.一种在开放式乳突切除术后同期进行乳突腔填塞和外耳道成形术的技术。
Auris Nasus Larynx. 2012 Dec;39(6):557-61. doi: 10.1016/j.anl.2011.11.004. Epub 2012 Feb 8.
3
Results of revision mastoidectomy.乳突改良根治术的结果。
Acta Otolaryngol. 2009 Feb;129(2):138-41. doi: 10.1080/00016480802140893.
4
Mastoid obliteration with S53P4 bioactive glass after canal wall down mastoidectomy: Preliminary results.鼓室成形术后 S53P4 生物活性玻璃乳突填塞:初步结果。
Am J Otolaryngol. 2021 Mar-Apr;42(2):102895. doi: 10.1016/j.amjoto.2020.102895. Epub 2021 Jan 5.
5
Obliteration of the persistently discharging mastoid cavity using the middle temporal artery flap.使用颞中动脉皮瓣封闭持续流脓的乳突腔。
Otolaryngol Head Neck Surg. 2007 Sep;137(3):433-8. doi: 10.1016/j.otohns.2007.02.034.
6
Mastoid obliteration with postconchal soft tissue and postauricular pericranial flap.使用耳甲腔后软组织和耳后颞肌筋膜瓣进行乳突腔闭塞术。
J Med Assoc Thai. 2012 Oct;95(10):1306-11.
7
Mastoid cavity obliteration: our experience.乳突腔闭塞:我们的经验
Otolaryngol Pol. 2012 Nov-Dec;66(6):379-81. doi: 10.1016/j.otpol.2012.08.001. Epub 2012 Sep 7.
8
Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage.生物活性玻璃S53P4在慢性中耳炎及脑脊液漏乳突根治术中的应用
Ann Otol Rhinol Laryngol. 2012 Sep;121(9):563-9. doi: 10.1177/000348941212100901.
9
Tympanoplasty, with or without mastoidectomy, is highly effective for treatment of chronic otitis media in children.鼓膜成形术,无论是否行乳突切除术,对治疗儿童慢性中耳炎都非常有效。
Acta Otolaryngol Suppl. 2007 Oct(558):44-8. doi: 10.1080/03655230701624855.
10
Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.生物活性玻璃填充乳突显著改善非胆脂瘤型慢性中耳炎患者的手术效果。
Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4121-4126. doi: 10.1007/s00405-017-4757-7. Epub 2017 Sep 27.

引用本文的文献

1
Mastoid Obliteration Using S53P4 Bioactive Glass Versus Mastoidectomy Alone for Refractory Chronic Suppurative Otitis Media.使用S53P4生物活性玻璃与单纯乳突根治术治疗难治性慢性化脓性中耳炎的乳突闭塞术
Otol Neurotol. 2025 Sep 1;46(8):949-955. doi: 10.1097/MAO.0000000000004545.
2
Borosilicate bioactive glass synergizing low-dose antibiotic loaded implants to combat bacteria through ATP disruption and oxidative stress to sequentially achieve osseointegration.硼硅酸盐生物活性玻璃协同负载低剂量抗生素的植入物,通过破坏三磷酸腺苷(ATP)和氧化应激来对抗细菌,从而依次实现骨整合。
Bioact Mater. 2024 Oct 18;44:184-204. doi: 10.1016/j.bioactmat.2024.10.009. eCollection 2025 Feb.
3
Heterologous Materials Are Really Better than Autologous in Tympanoplasty Mastoid Obliteration? A Systematic Review with Meta-Analysis.
同种异体材料在鼓室成形乳突填塞术中真的优于自体材料吗?一项系统评价与荟萃分析。
J Int Adv Otol. 2024 Sep 26;20(5):439-449. doi: 10.5152/iao.2024.241262.
4
Safety and Effectiveness of Bone Allografts for Mastoid Obliteration After Mastoidectomy: A Pilot Study.乳突切除术后骨移植用于乳突闭塞的安全性和有效性:一项初步研究。
J Audiol Otol. 2024 Jul;28(3):221-227. doi: 10.7874/jao.2023.00367. Epub 2024 Jul 2.
5
Antibiotics in mastoid and epitympanic obliteration with S53P4 bioactive glass: A retrospective study.S53P4生物活性玻璃用于乳突及鼓室上隐窝填塞时抗生素的应用:一项回顾性研究
Laryngoscope Investig Otolaryngol. 2022 Sep 14;7(5):1584-1594. doi: 10.1002/lio2.923. eCollection 2022 Oct.
6
Postoperative surgical site infection in cholesteatoma surgery with and without mastoid obliteration, what can we learn?胆脂瘤手术伴或不伴乳突充填术后手术部位感染,我们能学到什么?
J Otol. 2022 Jan;17(1):25-30. doi: 10.1016/j.joto.2021.10.001. Epub 2021 Oct 29.
7
Bioactive Glass Applications: A Literature Review of Human Clinical Trials.生物活性玻璃的应用:人体临床试验文献综述
Materials (Basel). 2021 Sep 20;14(18):5440. doi: 10.3390/ma14185440.
8
18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration.乳突切除术后生物活性玻璃S53P4诱导骨形成的18F-NaF PET/CT成像
Eur J Hybrid Imaging. 2019 Oct 31;3(1):18. doi: 10.1186/s41824-019-0065-3.
9
A Multicenter Retrospective Case Review of Outcomes and Complications of S53P4 Bioactive Glass.S53P4 生物活性玻璃的结果和并发症的多中心回顾性病例研究
J Int Adv Otol. 2021 May;17(3):234-238. doi: 10.5152/iao.2021.9053.
10
Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.使用S53P4生物活性玻璃进行乳突闭塞术后植入骨桥BCI 602:一种治疗复杂解剖条件的安全方法——初步结果。
Life (Basel). 2021 Apr 22;11(5):374. doi: 10.3390/life11050374.